Roxro Pharma

About:

Roxro Pharma offers ROX-888 and ROX-828, drugs developed for the treatment of pain.

Top Investors: Sutter Hill Ventures, Prospect Venture Partners, Thomas Weisel Partners

Description:

ROXRO PHARMA, Inc. develops drugs for pain treatment. Its products include ROX-888, an intranasal formulation for the treatment of dental and postoperative pain; and ROX-828, a non-opioid and non-triptan intranasal product for the treatment of migraine. ROXRO PHARMA, Inc. was founded in 1999 and is based in Menlo Park, California.

Total Funding Amount:

$68.8M

Headquarters Location:

Menlo Park, California, United States

Founded Date:

1999-01-01

Founders:

Number of Employees:

1-10

Last Funding Date:

2007-06-12

IPO Status:

Private

Industries: